Drug for dry mouth may prevent lung cancer
By Nathan Seppa
From San Francisco, at a meeting of the American Association for Cancer Research
A drug that has been prescribed for 30 years for a condition known as dry mouth can also stymie the formation of precancerous lung lesions in cigarette smokers, particularly those who have quit.
Solvay Pharma, a company based near Paris, markets the drug–anethole dithiolethione (ADT)–in several countries, including France and Canada, but has never sought regulatory approval for it in the United States.